Skip to main content
. Author manuscript; available in PMC: 2010 Oct 21.
Published in final edited form as: Transplant Proc. 1991 Apr;23(2):1888–1889.

Table 1.

Clinical Features and Outcome of Patients With Hemochromatosis

Age (Years) Sex Clinical Symptoms/Signs HLA Status Serum Iron Studies Grade or Iron Staining Duration of Venesection Outcome Follow-Up Period
41 M Diabetes, jaundice, variceal bleeding A3B7 4 7y Alive 4.5 y
44 M Variceal bleeding, jaundice A3B7 4 12 Y Alive 4.3 y
61 M Liver failure, hepatocellular CA A3B7 4 8 y Rejection, died 19 days after re-OLT
52 M Diabetes, pigmentation ND* 2 10 y Alive 5 y
45 M Chronic liver failure, encephalopathy, varices, arthropathy A3B7 4 3 y Alive 4 y
44 M Variceal bleeding, ascites, liver failure A3B7 4 6 y Alive 0.6 y
*

ND = not done.